Event: inhibited the proliferation of hepatocellular carcinoma cells, blocked the cell cycle to accelerate apoptosis, and attenuated the angiogenic activity of SGLT-2-expressing hepatocellular carcinoma mechanism: downregulated glycolytic metabolism through inhibiting extracellular signal-regulated kinase phosphorylation. Here, SLC5A2 is linked to hepatocellular carcinoma.